Literature DB >> 16525410

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study.

David J States1, Gilbert S Omenn, Thomas W Blackwell, Damian Fermin, Jimmy Eng, David W Speicher, Samir M Hanash.   

Abstract

The Human Proteome Organization (HUPO) recently completed the first large-scale collaborative study to characterize the human serum and plasma proteomes. The study was carried out in different locations and used diverse methods and instruments to compare and integrate tandem mass spectrometry (MS/MS) data on aliquots of pooled serum and plasma from healthy subjects. Liquid chromatography (LC)-MS/MS data sets from 18 laboratories were matched to the International Protein Index database, and an initial integration exercise resulted in 9,504 proteins identified with one or more peptides, and 3,020 proteins identified with two or more peptides. This article uses a rigorous statistical approach to take into account the length of coding regions in genes, and multiple hypothesis-testing techniques. On this basis, we now present a reduced set of 889 proteins identified with a confidence level of at least 95%. We also discuss the importance of such an integrated analysis in providing an accurate representation of a proteome as well as the value such data sets contain for the high-confidence identification of protein matches to novel exons, some of which may be localized in alternatively spliced forms of known plasma proteins and some in previously nonannotated gene sequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525410     DOI: 10.1038/nbt1183

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  97 in total

1.  Label-free protein quantitation using weighted spectral counting.

Authors:  Christine Vogel; Edward M Marcotte
Journal:  Methods Mol Biol       Date:  2012

2.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

3.  Generic comparison of protein inference engines.

Authors:  Manfred Claassen; Lukas Reiter; Michael O Hengartner; Joachim M Buhmann; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2011-11-04       Impact factor: 5.911

Review 4.  The grand challenge to decipher the cancer proteome.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Nat Rev Cancer       Date:  2010-09       Impact factor: 60.716

5.  Exploration of early-life candidate biomarkers for childhood asthma using antibody arrays.

Authors:  Haili Xu; Timothy Radabaugh; Zhenqiang Lu; Michael Galligan; Dean Billheimer; Donata Vercelli; Anne L Wright; Terrence J Monks; Marilyn Halonen; Serrine S Lau
Journal:  Pediatr Allergy Immunol       Date:  2016-09-12       Impact factor: 6.377

Review 6.  Comparative analysis of the liver and plasma proteomes as a novel and powerful strategy for hepatocellular carcinoma biomarker discovery.

Authors:  Laura Beretta
Journal:  Cancer Lett       Date:  2009-02-15       Impact factor: 8.679

Review 7.  Unleashing the power of proteomics to develop blood-based cancer markers.

Authors:  Ayumu Taguchi; Samir M Hanash
Journal:  Clin Chem       Date:  2012-10-24       Impact factor: 8.327

Review 8.  Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.

Authors:  J Gustav Smith; Robert E Gerszten
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

Review 9.  Generating disulfides with the Quiescin-sulfhydryl oxidases.

Authors:  Erin J Heckler; Pumtiwitt C Rancy; Vamsi K Kodali; Colin Thorpe
Journal:  Biochim Biophys Acta       Date:  2007-10-12

10.  Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins.

Authors:  Gilbert S Omenn
Journal:  Biochim Biophys Acta       Date:  2013-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.